Yazici, Ayten http://orcid.org/0000-0003-2167-4509
Özdemir Işık, Özlem
Dalkılıç, Ediz
Koca, Süleyman Serdar
Pehlivan, Yavuz
Şenel, Soner
Inanc, Nevsun
Akar, Servet
Yılmaz, Sema
Soysal Gündüz, Özgül
Cefle, Ayse
Karakaş, Ömer Fatih
Onen, Fatos
Article History
Received: 5 August 2022
Accepted: 9 December 2022
First Online: 20 December 2022
Competing interests
: AY reports grants from Roche, outside the submitted work. ED reports grants and personal fees from Pfizer, grants and personal fees from MSD, grants and personal fees from Novartis, grants and personal fees from UCB, grants and personal fees from Roche, outside the submitted work. SA reports grants from Lilly, grants from AbbVie, grants from UCB, grants from MSD, grants from Pfizer, grants from CellTrion. ÖSG reports personal fees from Pfizer, personal fees from AbbVie, personal fees from Merck. SA participated on a Data Safety Monitoring Board or an Advisory Board for Lilly, AbbVie, UCB, MSD, Pfizer, CellTrion. ÖFK is currently employed at Roche Turkey. The remaining authors have nothing to disclose.